Bain & Company January 7, 2026
Pharma can’t afford to keep AI experiments in the lab. Emerging industry leaders are accelerating clinical development by scaling cross-functional, human-centric systems.
At a Glance
- Clinical development has become the bottleneck between discovery and patient outcomes. Trials take longer, costs are soaring, and complexity is overwhelming.
- AI can deliver higher, faster ROI in clinical development than in most other areas in pharma.
- To get there, the industry needs to move beyond isolated pilots to automated orchestration that reduces friction across stakeholders, accelerates timelines, and improves quality.
- Leading companies are making their data AI-ready, building orchestrated AI systems, and using AI to amplify human judgment,...
Today's Sponsors
Today's Sponsor